Skip to content

Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis.

Oct 2026 · Phytomedicine · Vol 162, pp. 158886 · 0 citations · 56 references
Medicine

Abstract

Background

Doxorubicin (DOX) is widely employed as an antineoplastic agent in clinical settings, yet its therapeutic utility is constrained by dose-dependent cardiotoxicity, partly resulting from oxidative injury to cardiomyocytes and impairment of mitochondrial function. Hence, there is an urgent imperative to develop cardioprotective strategies targeting oxidative stress and mitochondrial dysfunction. Previous studies have suggested that isoliquiritigenin (Iso) confers protection against DOX-induced cardiomyopathy (DIC); however, the exact molecular mechanisms governing its pharmacological activity have yet to be elucidated.

Purpose

The objective of this study was to further explore the cardioprotective effects conferred by isoliquiritigenin (Iso) and to clarify the potential molecular mechanisms involved.

Methods

/STUDY DESIGNS Oxidative stress, mitochondrial function, myocardial injury, and intracellular calcium levels were examined in cardiomyocytes. In addition, mechanistic investigations were conducted using cardiomyocyte-specific Piezo1-knockdown mice generated by AAV9, along with EGTA treatment for calcium depletion, Piezo1 knockdown, and Pdk4 overexpression in cardiomyocytes.

Results

Treatment with Iso was found to significantly attenuate DOX-induced myocardial injury, histopathological damage, and apoptosis of cardiomyocytes in vivo. Moreover, in vitro experiments corroborated that Iso effectively rescued H9c2 cells and NMCMs from DOX-induced cytotoxicity, oxidative stress, and apoptosis. Further investigations revealed that isoliquiritigenin (Iso) preserved mitochondrial function through suppression of oxidative stress damage and restoration of the equilibrium between mitochondrial fusion and fission. The underlying mechanism revealed that Iso exerts its effects by targeting the Piezo1 mechanosensitive channel and subsequently modulating Pdk4 via Ca²⁺ signaling.

Conclusion

Collectively, our findings suggest that the cardioprotective efficacy of Iso against DOX-induced cardiotoxicity is mediated by the Piezo1-Ca²⁺-Pdk4 signaling pathway, which operates to attenuate oxidative insults, preserve mitochondrial integrity, and reduce apoptotic loss of cardiac myocytes.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.